74918-57-3

Basic information

• Product Name: Isopalmitic chloride
• Synonyms: Isopalmitic chloride
• CAS NO: 74918-57-3
• Molecular Formula: C16H31ClO
• Molecular Weight: 274.86974
• Mol File: 74918-57-3.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Isopalmitic chloride(CAS DataBase Reference)
• NIST Chemistry Reference: Isopalmitic chloride(74918-57-3)
• EPA Substance Registry System: Isopalmitic chloride(74918-57-3)

Safety Data

• Hazardous Substances Data: 74918-57-3(Hazardous Substances Data)

Usage

General Description

Isopalmitic chloride is a chemical compound with the formula C16H33Cl. It is a type of fatty acid chloride, derived from palmitic acid, which is a common saturated fatty acid found in many natural sources such as palm oil and animal fats. Isopalmitic chloride is used in the production of surfactants, emulsifiers, and other industrial applications. It is a versatile compound that can be utilized in various chemical processes, particularly in the synthesis of esters, amides, and other organic compounds. Isopalmitic chloride is known for its ability to contribute to the stability and functionality of various formulations in the cosmetic, pharmaceutical, and personal care industries. Overall, it is a valuable chemical that plays a crucial role in the manufacturing of a wide range of products.

Upstream product

• 25354-97-6 2-hexyldecanoic acid 

Downstream Products

• 62281-05-4 2-n-hexyldecan-1-amine 
• 2036272-55-4 1,2-distearoyl-sn-glycero-3-phosphocholine 

Relevant articles and documents

LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF ACTIVE AGENTS

Compounds are provided having the following structure: (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein G1, R1, R2, L, and n are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.

LIPID DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE

A method of treating a disease mediated by protein expression in adipose tissue by intraperitoneally administering a composition comprising a lipid nanoparticle encapsulating or associated with a therapeutic agent (e.g., a nucleic acid), thereby delivering the therapeutic agent to adipose tissue of the subject and altering protein expression in the adipose tissue is provided herein. A method for delivering a therapeutic agent to adipose tissue of a subject in need thereof is also provided.

Method for cleaving alpha carbon-carbon single bonds in ketone under condition of metal-free catalysis

The invention discloses a method for selectively activating and cleaving alpha carbon-carbon single bonds in ketone under the condition of metal-free catalysis. The method is characterized in that the alpha carbon-carbon single bonds in the ketone are activated and cleaved by solvent induction and driving of intermediate structure factors formed by the ketone and hydrazine without metal catalysts. Transition metal for catalysis is omitted, the method is environmentally friendly, reaction cost is reduced to a certain degree, methodology of selective cleavage of the carbon-carbon single bonds is enriched, and a new idea is provided for activation of inertial chemical bonds under mild conditions.